Results

Total Results: 1,636 records

Showing results for "treated".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_consumer.pdf
    July 01, 2016 - Understanding Your Options How is FI treated?
  2. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
    January 01, 2012 - Authors reported the following: Patients treated with Qnexa had significant, sustained weight loss … that for patients completing the 12-week study, mean excess weight loss was 19.0% in the EndoBarrier-treated
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0012_03-21-2008.pdf
    January 01, 2008 - Effective Health Care Topic Number(s): 0064 Document Completion Date: 11-18-09 1 Results of Topic Selection Process & Next Steps  Subclinical hypothyroidism will go forward for refinement as a comparative effectiveness or effectiveness review. Although the topic was initially thought to be cove…
  4. S149 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
    October 01, 2007 - Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with … Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients … Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated
  5. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
    October 01, 2011 - About 3.7 additional cardiovascular events occurred for every 1,000 patients treated for one year with … celecoxib instead of placebo, or 1 additional cardiovascular event for every 270 patients treated for … infarction relative to placebo. 1 additional myocardial infarction occurred for about every 300 patients treated
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-214-afib-disposition-comments.pdf
    October 30, 2019 - The “as treated” (treatment received) analysis compares the actually received treatments. … Although “as treated” analyses can be useful, most often they are considered secondary to the ITT … We have included the as- treated findings in the main results text but focus on the ITT findings in … We have included the as- treated findings in the main results text but focus on the ITT findings in … Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin
  7. effectivehealthcare.ahrq.gov/sites/default/files/ch-7-user-guide-to-ocer_130129.pdf
    March 29, 2012 - An “as treated” analysis allows subjects to switch treatment groups on the basis of their use of treatment … Both the “as treated” and “per protocol” analysis can be used to evaluate time-varying treatment. … treatment in the same direction, and should always affect the outcome in the same direction for both the treated … If an increase in the confounder increased the outcome for the treated group and decreased the outcome … result, and procedure code, along with any electronically accessible narrative statements, can be treated
  8. effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - This finding implies that both “how” and “when” patients are treated are key to any successful therapies
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_research-protocol.pdf
    January 01, 2020 - lumbar bone mineral density, bone turnover, and chronic back pain in post- menopausal osteoporotic women treated
  10. effectivehealthcare.ahrq.gov/sites/default/files/nt_docs/topic-brief-updating-pharmacotherapy.pdf
    September 30, 2022 - addressed and/or is improving when higher proportions of patients with alcohol use disorder are being treated
  11. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0645-151012.pdf
    August 05, 2015 - Untitled     Anxiety Disorders in Children Nomination Summary Document Results of Topic Selection Process & Next Steps § The topic, Anxiety Disorders in Children, will go forward for re…
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/emt-naloxon_research-protocol.pdf
    November 29, 2016 - Key Question 3: For patients with confirmed or suspected opioid overdose in out-of- hospital settings treated … suspected opioid overdose who exhibit altered mental status, miosis or respiratory depression and who are treated … due solely to trauma, hypoxia or ethanol ingestion, and patients without signs of opioid overdose treated … suspected opioid overdose who exhibit altered mental status, miosis or respiratory distress and who are treated
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_protocol-140716.pdf
    April 03, 2014 - Insomnia is often treated with prescription medication. … anxiety, osteoarthritis and other conditions prevalent among those with insomnia disorder and commonly treated … sleep medicine clinics may not produce results applicable to the general population of patients being treated … Discontinuation of benzodiazepines among older insomniac adults treated with cognitive- behavioural
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_research-protocol.pdf
    April 03, 2014 - Insomnia is often treated with prescription medication. … anxiety, osteoarthritis and other conditions prevalent among those with insomnia disorder and commonly treated … sleep medicine clinics may not produce results applicable to the general population of patients being treated … Discontinuation of benzodiazepines among older insomniac adults treated with cognitive- behavioural
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_policymaker.pdf
    June 01, 2016 - Management of Infantile Hemangioma B A C K G R O U N D Infantile hemangioma (IH) is generally a benign vascular neoplasm. The International Society for the Study of Vascular Anomalies (ISSVA) classifies IH lesions as vascular tumors, which are differentiated from vascular malformations.2 IH affects 4 to 5 perce…
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
    April 01, 2019 - with alendronate for 4 years or with osteopenia or osteoporosis treated with zoledronate for 6 years … Analogously, for every 1,000 women previously treated for osteopenia or osteoporosis with 3 to 5 years … Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results … The risk of osteonecrosis of the jaws in Taiwanese osteoporotic patients treated with oral alendronate … Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
    May 07, 2010 - Although ACEIs and ARBs both target the renin system and are treated equivalently by clinicians, this
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdf
    June 01, 2018 - Antipsychotics for the Prevention and Treatment of Delirium: A Systematic Review Evidence-based Practice Center Systematic Review Protocol Project Title: Antipsychotics for the Prevention and Treatment of Delirium: A Systematic Review. (Amendments Details–see Section VII) I. Background and Objectives…
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/delirium-disposition-comments.pdf
    September 03, 2019 - The text states: For those being treated for delirium in palliative care or hospice settings, haloperidol … second-generation antipsychotics may have slightly less improvement in delirium severity than those treated … We have changed the sentence to read, “Patients being treated with haloperidol or second-generation
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-g-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - RCTs Table G-1. Quality assessments of included randomized controlled trials Author, Year Randomization Adequate Allocation Concealment Adequate Patients and Personnel Masked Outcome Assessors Masked Groups Similar at Baseline Intent-to-Treat Analysis (at Least 95% Analyzed) Attrition <20%; Difference Between Groups …

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: